Alectinib Monotherapy in Isolated Central Nervous System Relapse of ALK-Positive Anaplastic Large Cell Lymphoma
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK-positive ALCL) is an aggressive form of peripheral T cell lymphoma (PTCL), harbouring an underlying pathogenic ALK fusion gene that produces a constitutively activated tyrosine kinase. The ALK tyrosine kinase provides a targeted...
Saved in:
| Main Authors: | Julian Verran, Vidya Mathavan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2022/4749452 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)
by: YuE Vinogradova, et al.
Published: (2019-03-01) -
MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01) -
An Isolated Cutaneous Relapse in a Known Case of Systemic ALK-Positive Anaplastic Large Cell Lymphoma: A Rare Case Report with Review of Literature
by: Monisha Shetty, et al. -
Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report
by: Satoshi Mitsuyuki, et al.
Published: (2025-04-01) -
ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib
by: Ray Sagawa, et al.
Published: (2018-01-01)